Does CPT1b deficiency aggravate pressure overload-induced cardiac hypertrophy?
CPT1b deficiency exacerbates cardiac hypertrophy under pressure overload via lipotoxicity, suggesting caution with the clinical use of CPT1 inhibitors.
CPT1b deficiency can cause lipotoxicity in the heart under pathological stress, leading to exacerbation of cardiac pathology. Therefore, caution should be exercised in the clinical use of CPT1 inhibitors.
He et al. (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: